
Euan Ashley
Professor, Genomics & Precision Health
Stanford

Molly He
CEO
Element Bioscience

Alex Aravanis
CTO
Illumina

Sarah Hersey
VP, Precision Medicine
Bristol Myers Squibb

Bruce J. Tromberg
Director
National Institute of Biomedical Imaging and Bioengineering, NIH

Mara Aspinall
Managing Director
BlueStone Venture Partners

Stephen F. Kingsmore
President & CEO
Rady Children’s Institute for Genomic Medicine

Esther Babady
Section Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center

Eric Dishman
Former Director, All of Us Research Program
NIH

Alicyn Campbell
Head, Digital Health Oncology
AstraZeneca

Christopher M. Hartshorn
Chief, Digital & Mobile Technologies
NCATS, NIH

Razelle Kurzrock
Chair, Clinical Trials Committee
WIN for Personalized Cancer Therapy

Howard I. Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center

Jacqueline Shreibati
Senior Clinical Lead, Consumer Health
Google

Tom Miller
Managing Partner
GreyBird Ventures

Lourdes Barrera
Executive Director, Precision Medicine
Merck

Philip E. Castle
Director, Cancer Prevention
NCI, NIH

Hoi-Ying Elsie Yu
Director, Point-of-Care Testing
Geisinger Health System

Nathan Ledeboer
Vice Chair, Pathology
Medical College of Wisconsin

Michael Snyder
Director, Genomics & Personalized Medicine
Stanford University

Edward Abrahams
President
Personalized Medicine Coalition

Marielena Mata
Diagnostic Lead, Oncology
Pfizer

Christopher Conn
Global Director, Diagnostics Strategy
Amgen

Larry Kessler
Deputy Chair
MCED Consortium

Kenna R. Mills-Shaw
Executive Director, Personalized Cancer Therapy
MD Anderson Cancer Center

Dave Persing
CSO, Cepheid
CSO, Danaher Diagnostics

Cindy Perettie
Head
Roche Molecular Labs

William G. Morice II
CEO
Mayo Clinic Laboratories

Robert J. Bujarski
President and COO
QuidelOrtho

Jay Wohlgemuth
CMO
Quest Diagnostics